After breast cancer at 30, Aisha shares her journey through motherhood, a double mastectomy, body image struggles and the challenges of survivorship.
News|Videos|August 19, 2016
Fatigue or Autoimmune Disease? Physician Talks Immunotherapy Side Effects
Author(s)Yvonne Saenger, MD
Yvonne Saenger, director of melanoma and immunotherapy at Columbia University Medical Center, discusses the side effects patients should look out for when they are on immunotherapy, and how to determine if they are experiencing normal therapy-induced fatigue or if they are suffering from a hormone reaction and should go see their medical team.
Advertisement
Yvonne Saenger, director of melanoma and immunotherapy at Columbia University Medical Center, discusses the side effects patients should look out for when they are on immunotherapy, and how to determine if they are experiencing normal therapy-induced fatigue or if they are suffering from a hormone reaction and should go see their medical team at the Society for Immunotherapy of Cancer (SITC) 101 session.
Advertisement
Related to this article
Emma Halligan found connection at a free New Jersey retreat for women with cancer, which held its annual walk and 5K on Oct. 17.
Diagnosed with stage 4 breast cancer weeks after giving birth, Eileen Carter explains why getting a second opinion changed the course of her care.
Libtayo survival data, a rare positive osteosarcoma trial and new ADCs for breast, lung and stomach cancers are among ESMO 2026 abstracts to watch.
Noah Elliott, now a Paralympic snowboarder, counted small wins during inpatient chemotherapy and found inspiration in the youngest children on his hospital floor.
The FDA grants traditional approval to Keytruda and Keytruda Qlex for TMB-H solid tumors, updating the threshold to at least 13 mutations per megabase.
Martha Carlson reflects on her 11 years with metastatic breast cancer and explores how resilience, purpose and the stories we tell ourselves shape the cancer experience.
A study found that 1 in 9 older cancer survivors developed a second cancer, highlighting why routine screening remains important beyond five years.
Advertisement
Advertisement
Trending on CURE
1
New Myelofibrosis Guidelines Back Wider Gene Testing at Diagnosis
2
FDA Approves Jemperli for dMMR Locally Advanced Rectal Cancer
3
FDA Clears AI Tool Using MRI to Gauge Breast Cancer Recurrence
4
Why Cancer Screening Remains Important for Long-Term Cancer Survivors
5